General Information of Drug (ID: DMYZRTB)

Drug Name
Nojirimycine Tetrazole Drug Info
Synonyms nojirimycine tetrazole; (5R,6R,7S,8S)-5-(hydroxymethyl)-5,6,7,8-tetrahydrotetrazolo[1,5-a]pyridine-6,7,8-triol; Gluco-tetrazole; 1noi; 1nok; 1noj; 2j7b; AC1L9HNU; ZINC17193216
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
445245
TTD Drug ID
DMYZRTB

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Investigative Drug(s)
Clinical Trial Drug(s)
Discontinued Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Alpha-D-Mannose DMF5DLW Discovery agent N.A. Investigative [2]
Fucose DMAHMSV N. A. N. A. Investigative [2]
2,5-dideoxy-2,5-imino-D-altritol DMI1O54 Discovery agent N.A. Investigative [3]
Gluconolactone DMO071E Discovery agent N.A. Investigative [1]
ETHYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE DM0O4A2 Discovery agent N.A. Investigative [1]
Hyacinthacine B3 DMJ9KNU Discovery agent N.A. Investigative [4]
D-Gluconhydroximo-1,5-Lactam DM527XP Discovery agent N.A. Investigative [1]
2,5-dideoxy-2,5-imino-dl-glycero-D-manno-heptitol DMKP7O0 Discovery agent N.A. Investigative [5]
2-Deoxy-2fluoro-Glucose DMMC8IG Discovery agent N.A. Investigative [2]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
URSOLIC ACID DM4SOAW Metabolic syndrome x 5C50-5D2Z Phase 2 [6]
JTT-651 DMGP42Q Type-2 diabetes 5A11 Discontinued in Phase 1 [7]
L-serine-O-phosphate DMTJ1NH Discovery agent N.A. Investigative [2]
Beta-D-Glucose DM5IHYP Discovery agent N.A. Investigative [2]
Indirubin-5-sulfonate DM08VHZ Discovery agent N.A. Investigative [2]
Inosinic Acid DMLR86H Discovery agent N.A. Investigative [2]
Alpha-D-Glucose-6-Phosphate DMR0EVN Discovery agent N.A. Investigative [2]
N'-Pyridoxyl-Lysine-5'-Monophosphate DM3ZHBO Discovery agent N.A. Investigative [2]
OLEANOLIC_ACID DMWDMJ3 Discovery agent N.A. Investigative [8]
Oleanonic acid DMYPJC3 Discovery agent N.A. Investigative [8]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Glycogen phosphorylase muscle form (GP) TTZHY6R PYGM_HUMAN Inhibitor [1]
Lactase-phlorizin hydrolase (LCT) TTA0OSE LPH_HUMAN Inhibitor [1]

References

1 The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
2 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
3 2,5-Dideoxy-2,5-imino-d-altritol as a new class of pharmacological chaperone for Fabry disease. Bioorg Med Chem. 2010 Jun 1;18(11):3790-4.
4 New polyhydroxylated pyrrolidine, piperidine, and pyrrolizidine alkaloids from Scilla sibirica. J Nat Prod. 2002 Dec;65(12):1875-81.
5 Nitrogen-containing furanose and pyranose analogues from Hyacinthus orientalis. J Nat Prod. 1998 May;61(5):625-8.
6 Synthesis of 3-deoxypentacyclic triterpene derivatives as inhibitors of glycogen phosphorylase. J Nat Prod. 2009 Aug;72(8):1414-8.
7 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800026877)
8 Naturally occurring pentacyclic triterpenes as inhibitors of glycogen phosphorylase: synthesis, structure-activity relationships, and X-ray crystal... J Med Chem. 2008 Jun 26;51(12):3540-54.